Cholesterol, lipoproteins, high-sensitivity c-reactive protein, and other risk factors for atherosclerosis

Joseph Rudolf, Kent B. Lewandrowski

Research output: Contribution to journalReview articlepeer-review

31 Scopus citations


Coronary heart disease is a common and costly epidemic in the Western world. Intensive study has led to a deeper understanding of the pathogenesis of coronary disease and risk stratification. Traditional risk factor assessment has focused on parameters derived from the Framingham Heart Study (age, hypertension, cholesterol, family history, and cigarette smoking). New emerging risk factors, both biological and genetic, are reshaping the understanding of heart disease and the approach to risk stratification. As these emerging assays become more standardized, automated, and inexpensive to perform, they are becoming increasingly important tools in the assessment and treatment of coronary heart disease.

Original languageEnglish (US)
Pages (from-to)113-127
Number of pages15
JournalClinics in Laboratory Medicine
Issue number1
StatePublished - Mar 2014

Bibliographical note

Copyright 2014 Elsevier B.V., All rights reserved.


  • Apolipoprotein E
  • Atherosclerosis
  • Biomarkers
  • Cardiac markers
  • Cholesterol biomarker
  • High-sensitivity CRP
  • Laboratory medicine
  • Lipoprotein


Dive into the research topics of 'Cholesterol, lipoproteins, high-sensitivity c-reactive protein, and other risk factors for atherosclerosis'. Together they form a unique fingerprint.

Cite this